HK1176280A1 - Stable liquid pharmaceutical composition based on trazodone - Google Patents

Stable liquid pharmaceutical composition based on trazodone

Info

Publication number
HK1176280A1
HK1176280A1 HK13102337.3A HK13102337A HK1176280A1 HK 1176280 A1 HK1176280 A1 HK 1176280A1 HK 13102337 A HK13102337 A HK 13102337A HK 1176280 A1 HK1176280 A1 HK 1176280A1
Authority
HK
Hong Kong
Prior art keywords
trazodone
pharmaceutical composition
liquid pharmaceutical
composition based
stable liquid
Prior art date
Application number
HK13102337.3A
Other languages
English (en)
Chinese (zh)
Inventor
Marcello Marchetti
Francesca Mariotti
Lorella Ragni
Paolo Scarpetti
Mauro Valenti
Original Assignee
Acraf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Acraf filed Critical Acraf
Publication of HK1176280A1 publication Critical patent/HK1176280A1/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Nutrition Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Physiology (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
HK13102337.3A 2007-07-31 2010-05-19 Stable liquid pharmaceutical composition based on trazodone HK1176280A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT001573A ITMI20071573A1 (it) 2007-07-31 2007-07-31 Composizione farmaceutica liquida stabile a base di trazodone

Publications (1)

Publication Number Publication Date
HK1176280A1 true HK1176280A1 (en) 2013-07-26

Family

ID=38858941

Family Applications (2)

Application Number Title Priority Date Filing Date
HK10104941.0A HK1138207A1 (en) 2007-07-31 2010-05-19 Stable liquid pharmaceutical composition based on trazodone
HK13102337.3A HK1176280A1 (en) 2007-07-31 2010-05-19 Stable liquid pharmaceutical composition based on trazodone

Family Applications Before (1)

Application Number Title Priority Date Filing Date
HK10104941.0A HK1138207A1 (en) 2007-07-31 2010-05-19 Stable liquid pharmaceutical composition based on trazodone

Country Status (25)

Country Link
US (1) US10292931B2 (da)
EP (2) EP2494955B1 (da)
JP (1) JP5426548B2 (da)
KR (1) KR101493370B1 (da)
CN (1) CN101784257B (da)
AR (1) AR068327A1 (da)
AU (1) AU2008281858B2 (da)
BR (1) BRPI0814658A2 (da)
CA (1) CA2692975C (da)
CY (1) CY1116189T1 (da)
DK (2) DK2494955T3 (da)
EA (1) EA016822B1 (da)
ES (2) ES2399569T3 (da)
GE (1) GEP20125525B (da)
HK (2) HK1138207A1 (da)
HR (1) HRP20150349T1 (da)
IL (1) IL203167A (da)
IT (1) ITMI20071573A1 (da)
MX (1) MX2010001092A (da)
PL (2) PL2494955T3 (da)
PT (2) PT2182920E (da)
SG (1) SG183659A1 (da)
SI (2) SI2494955T1 (da)
UA (1) UA102376C2 (da)
WO (1) WO2009016069A2 (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20071603A1 (it) 2007-08-03 2009-02-04 Acraf Trazodone e trazodone cloridrato in forma purificata
WO2012072665A1 (en) 2010-11-30 2012-06-07 Pharmaneuroboost N.V. Compositions comprising pipamperone and serotonin antagonist reuptake inhibitors
RU2706700C1 (ru) * 2019-09-24 2019-11-20 Общество с ограниченной ответственностью "Научно-производственная компания "СКиФФ" Фармацевтическая композиция для коррекции поведения кошек и собак в стрессовых ситуациях
CA3153639A1 (en) * 2019-09-26 2021-04-01 Angelini S.P.A. Pediatric trazodone compositions and method of treatment thereof
CN111568861A (zh) * 2020-05-25 2020-08-25 河北科星药业有限公司 畜禽用盐酸溴己新口服液及其制备方法和应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4154832A (en) * 1974-08-26 1979-05-15 Bruno Silvestrini Novel treatment for acute organic cerebral syndromes (strokes)
IT1233412B (it) * 1987-12-02 1992-03-30 Acraf Uso del trazodone
CA2338457C (en) 1998-07-24 2009-11-17 Seo Hong Yoo Preparation of aqueous clear solution dosage forms with bile acids
AU2003903597A0 (en) * 2003-07-11 2003-07-24 Jakov Vaisman Treatment of premature ejaculation
ITMI20071603A1 (it) 2007-08-03 2009-02-04 Acraf Trazodone e trazodone cloridrato in forma purificata

Also Published As

Publication number Publication date
KR101493370B1 (ko) 2015-02-13
ES2531241T3 (es) 2015-03-12
EA201070194A1 (ru) 2010-06-30
MX2010001092A (es) 2010-03-01
EP2182920A2 (en) 2010-05-12
ES2399569T3 (es) 2013-04-02
AU2008281858B2 (en) 2014-02-27
EP2494955B1 (en) 2015-01-21
KR20100038112A (ko) 2010-04-12
EP2494955A3 (en) 2012-10-03
IL203167A (en) 2017-08-31
CA2692975C (en) 2016-01-12
PL2182920T3 (pl) 2013-05-31
PL2494955T3 (pl) 2015-06-30
WO2009016069A4 (en) 2009-05-14
CN101784257A (zh) 2010-07-21
PT2182920E (pt) 2013-03-07
UA102376C2 (ru) 2013-07-10
WO2009016069A3 (en) 2009-03-19
ITMI20071573A1 (it) 2009-02-01
EA016822B1 (ru) 2012-07-30
EP2494955A2 (en) 2012-09-05
SG183659A1 (en) 2012-09-27
WO2009016069A2 (en) 2009-02-05
AU2008281858A1 (en) 2009-02-05
US10292931B2 (en) 2019-05-21
JP2010534703A (ja) 2010-11-11
SI2182920T1 (sl) 2013-04-30
US20100256159A1 (en) 2010-10-07
CY1116189T1 (el) 2017-02-08
EP2182920B1 (en) 2012-12-26
CN101784257B (zh) 2012-11-28
DK2182920T3 (da) 2013-03-04
BRPI0814658A2 (pt) 2015-02-18
DK2494955T3 (da) 2015-04-13
SI2494955T1 (sl) 2015-04-30
HRP20150349T1 (hr) 2015-05-22
CA2692975A1 (en) 2009-02-05
AR068327A1 (es) 2009-11-11
HK1138207A1 (en) 2010-08-20
JP5426548B2 (ja) 2014-02-26
PT2494955E (pt) 2015-03-04
GEP20125525B (en) 2012-05-25

Similar Documents

Publication Publication Date Title
HUS1800007I1 (hu) Gyógyászati készítmény
PT1986606T (pt) Formulações líquidas contendo fenilefrina
EP2133095A4 (en) PHARMACEUTICAL COMPOSITION
EP2133094A4 (en) PHARMACEUTICAL COMPOSITION
EP2191826A4 (en) PHARMACEUTICAL COMPOSITION
IL200125A0 (en) Pharmaceutical composition
EP2224805A4 (en) PHARMACEUTICAL COMPOSITION
LT2966175T (lt) Farmacinės kompozicijos turinčios korteksolono-17-alfa-propionato
EP2224915A4 (en) PHARMACEUTICAL COMPOSITIONS
PL394605A1 (pl) Trwała złożona kompozycja farmaceutyczna
HK1138774A1 (en) Pharmaceutical composition
EP2224808A4 (en) PHARMACEUTICAL COMPOSITION
HK1138207A1 (en) Stable liquid pharmaceutical composition based on trazodone
EP2156832A4 (en) PHARMACEUTICAL COMPOSITION
IL195034A0 (en) Liquid pharmaceutical formulation
EP2224806A4 (en) PHARMACEUTICAL COMPOSITION
IL205975A0 (en) Pharmaceutical composition
HK1144295A1 (en) Stable liquid formulation
HK1182939A1 (en) Stable pharmaceutical composition
IL205931A0 (en) Pharmaceutical composition
HU0700755D0 (en) Pharmaceutical compositions containing capsaicionid
GB0717036D0 (en) Pharmaceutical composition
GB0712558D0 (en) Pharmaceutical composition